NLRP6 and infection: Studies have shown that NLRP6 and NLRP12 can act as a negative regulator of the NF-κB and mitogen-activated protein kinase (MAPK) signal pathways to attenuate intestinal inflammation during the infection of K. pneumoniae (Ghimire et al., 2020).